BINV.ST

BioInvent International AB (publ) [BINV.ST] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BINV.ST Stock Summary

Top BINV.ST Correlated Resources

BINV.ST


Top 10 Correlated ETFs

BINV.ST


Top 10 Correlated Stocks

BINV.ST


BINV.ST Financial details

Company Rating
Buy
Market Cap
2.35B
Income
-42.93M
Revenue
310.39M
Book val./share
28.77
Cash/share
20.89
Dividend
-
Dividend %
-
Employees
93
Optionable
No
Shortable
Yes
Earnings
22 Feb 2023
P/E
-8.27
Forward P/E
-
PEG
0.96
P/S
7.1
P/B
1.31
P/C
1.71
P/FCF
-40.47
Quick Ratio
22.75
Current Ratio
23.6
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.37
EPS next Y
-
EPS next Q
-
EPS this Y
-0.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-19.97%
Revenue last 5Y
-15.51%
Revenue Q/Q
-93.39%
EPS Q/Q
-138.14%
-
-
-
-
SMA20
-5.26%
SMA50
-18.18%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-3%
ROC
-0.03%
Gross Margin
-
Oper. Margin
-16%
Profit Margin
-14%
Payout
-
Shs Outstand
64.97M
Shs Float
40.25M
-
-
-
-
Target Price
-
52W Range
29.9-51.1
52W High
-29.9%
52W Low
+23.28%
RSI
41
Rel Volume
2.99
Avg Volume
49.71K
Volume
148.86K
Perf Week
0.56%
Perf Month
-11.29%
Perf Quarter
-19.48%
Perf Half Y
-10.51%
-
-
-
-
Beta
0.404427
-
-
Volatility
0.23%, 1.4%
Prev Close
-1.65%
Price
35.75
Change
-3.64%

BINV.ST Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
3.622.785.085.130.18
Net income per share
-8.08-8.89-7.51-2.66-2.65
Operating cash flow per share
-6.1-10.2-6.79-2.18-2.34
Free cash flow per share
-7.42-10.48-7-2.41-2.47
Cash per share
10.754.978.3425.410.32
Book value per share
10.476.329.1825.8913.03
Tangible book value per share
10.476.329.1825.8913.03
Share holders equity per share
10.476.329.1825.8913.03
Interest debt per share
000.870.420.28
Market cap
679.47M773.99M751.95M1.65B4.03B
Enterprise value
575.77M705.14M613.5M933.5M3.15B
P/E ratio
-6.76-6.28-5.42-21.63-14.47
Price to sales ratio
15.0920.088.0211.2207.81
POCF ratio
-8.96-5.47-6-26.37-16.38
PFCF ratio
-7.36-5.33-5.82-23.82-15.55
P/B Ratio
5.228.834.442.222.95
PTB ratio
5.228.834.442.222.95
EV to sales
12.7918.296.546.33162.29
Enterprise value over EBITDA
-5.9-5.97-4.85-14.59-11.95
EV to operating cash flow
-7.59-4.99-4.89-14.91-12.8
EV to free cash flow
-6.23-4.85-4.75-13.47-12.14
Earnings yield
-0.15-0.16-0.18-0.05-0.07
Free cash flow yield
-0.14-0.19-0.17-0.04-0.06
Debt to equity
000.060.010.02
Debt to assets
0.230.270.250.070.06
Net debt to EBITDA
1.060.581.0911.213.35
Current ratio
3.793.124.0914.4518.98
Interest coverage
-25.59K-20.51K-284.23-223.09-538.39
Income quality
0.751.150.90.820.88
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.870.730.3102.03
Research and developement to revenue
2.443.642.221.313.33
Intangibles to total assets
00000
Capex to operating cash flow
0.220.030.030.110.05
Capex to revenue
-0.37-0.1-0.04-0.05-0.68
Capex to depreciation
-5.72-0.76-0.33-0.56-0.91
Stock based compensation to revenue
00000
Graham number
43.6335.5639.3739.3527.9
ROIC
-0.79-1.4-0.77-0.1-0.2
Return on tangible assets
-0.59-1.02-0.61-0.1-0.19
Graham Net
7.652.715.4223.419.64
Working capital
110.98M69.59M145.9M719.54M1.06B
Tangible asset value
00000
Net current asset value
110.98M69.59M136.43M713.9M1.04B
Invested capital
000.090.020.02
Average receivables
00000
Average payables
15.54M13.87M15.64M16.91M18.32M
Average inventory
3.23M3.51M4.73M4.08M10.46M
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.77-1.41-0.82-0.1-0.2
Capex per share
-1.32-0.28-0.21-0.23-0.13

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.050.060.294.630.31
Net income per share
-1.07-0.98-1.162.86-1.09
Operating cash flow per share
-0.98-0.94-1.37-1.072.95
Free cash flow per share
-1.08-0.98-1.41-1.12.93
Cash per share
21.4813.4517.2416.720.89
Book value per share
24.7116.9822.2525.0628.77
Tangible book value per share
24.7116.9822.2525.0628.77
Share holders equity per share
24.7116.9822.2525.0628.77
Interest debt per share
0.510.350.460.430.4
Market cap
2.15B3.72B2.59B2.63B2.78B
Enterprise value
919.55M2.84B1.85B2.06B2.11B
P/E ratio
-8.57-11.81-9.563.92-10.87
Price to sales ratio
717.05758.66155.599.7155.03
POCF ratio
-37.33-49.11-32.48-42.0416.08
PFCF ratio
-34.08-47.26-31.38-40.6416.2
P/B Ratio
1.482.721.991.791.65
PTB ratio
1.482.721.991.791.65
EV to sales
307.23578.69110.997.61117.49
Enterprise value over EBITDA
-15.66-37.79-28.7712.06-34.96
EV to operating cash flow
-15.99-37.46-23.17-32.9912.19
EV to free cash flow
-14.6-36.05-22.39-31.8912.28
Earnings yield
-0.03-0.02-0.030.06-0.02
Free cash flow yield
-0.03-0.02-0.03-0.020.06
Debt to equity
0.020.020.020.010.01
Debt to assets
0.050.060.060.060.04
Net debt to EBITDA
20.8911.7511.56-3.3111.17
Current ratio
24.7618.9817.2317.9823.6
Interest coverage
00000
Income quality
0.920.961.18-0.37-2.71
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.612.440.790.040.58
Research and developement to revenue
19.2614.374.310.344.33
Intangibles to total assets
00000
Capex to operating cash flow
0.10.040.040.03-0.01
Capex to revenue
-1.83-0.6-0.17-0.01-0.07
Capex to depreciation
-1.41-0.81-0.8-0.6-0.34
Stock based compensation to revenue
00000
Graham number
24.3919.3324.140.1626.57
ROIC
-0.04-0.06-0.050.11-0.04
Return on tangible assets
-0.04-0.05-0.050.11-0.04
Graham Net
20.3112.5615.9615.2819.78
Working capital
1.23B1.06B996.82M1.2B1.22B
Tangible asset value
00000
Net current asset value
1.21B1.04B976.77M1.18B1.2B
Invested capital
0.020.020.020.020.01
Average receivables
00000
Average payables
00000
Average inventory
12.65M14.51M12.83M12.17M11.71M
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.04-0.06-0.050.11-0.04
Capex per share
-0.09-0.04-0.05-0.04-0.02

BINV.ST Frequently Asked Questions

What is BioInvent International AB (publ) stock symbol ?

BioInvent International AB (publ) is a SE stock and trading under the symbol BINV.ST

What is BioInvent International AB (publ) stock quote today ?

BioInvent International AB (publ) stock price is $35.75 today.

Is BioInvent International AB (publ) stock public?

Yes, BioInvent International AB (publ) is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap